SCHEMBL18564794

SCHEMBL18564794

Cn1c2ccc(N(c3ccccc3)c3ccc(-c4ccccc4)cc3)cc2c2c3ccccc3c3ccccc3c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 1/20 0.36
▸ TSPO P30536 1/20 0.35
▸ ALKBH5 Q6P6C2 1/20 0.35
▸ FTO Q9C0B1 1/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ KDM4E B2RXH2 4/20 0.34
▸ MAPT P10636 1/20 0.34
▸ LIMK1 P53667 1/20 0.34
▸ SLC2A1 P11166 1/20 0.33
▸ RXRA P19793 1/20 0.32
▸ RXRB P28702 1/20 0.32
▸ LMNA P02545 3/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ GAA P10253 2/20 0.32
▸ GLA P06280 1/20 0.32
▸ GPR3 P46089 1/20 0.32
▸ RET P07949 1/20 0.31
▸ CHEK1 O14757 1/20 0.31
▸ WEE1 P30291 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18564941 0.95 ALKBH5 (0.36) MAOBTSPOALKBH5FTOHSD17B10
SCHEMBL18564915 0.95 TSPO (0.40) MAOBTSPOALKBH5FTOHSD17B10
SCHEMBL18564826 0.95 TSPO (0.40) MAOBTSPOALKBH5FTOHSD17B10
SCHEMBL18564763 0.95 ALKBH5 (0.38) ALKBH5FTOHSD17B10HPGDKDM4E
SCHEMBL18564955 0.94 TSPO (0.38) MAOBTSPOALKBH5FTOHSD17B10
SCHEMBL18564942 0.94 TSPO (0.38) MAOBTSPOALKBH5FTOHSD17B10
SCHEMBL18564795 0.93 TSPO (0.38) MAOBTSPOALKBH5FTOHSD17B10
SCHEMBL18564771 0.93 TSPO (0.38) MAOBTSPOALKBH5FTOHSD17B10
SCHEMBL18121018 0.92 TSPO (0.39) MAOBTSPOALKBH5FTOHSD17B10
SCHEMBL18564837 0.90 MAOB (0.41) MAOBTSPOALKBH5FTOHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 — — US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 MAOB 760/4885TSPO 3292/4885ALKBH5 265/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 MAOB 760/4885TSPO 3292/4885ALKBH5 265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback